The drug eplerenone is usually prescribed for treating chronic heart failure. Now a study at University Hospital in Southampton, UK, is showing that it may work for a currently untreatable eye condition, the website heart.co.uk reports.
Central serous chorioretinopathy (CSCR) is a type of macular degeneration that mainly affects people in their 30s and 40s. It occurs when fluid gathers under the retina and damages the tissue.
Professor Andrew Lotery, a consultant ophthalmologist at the hospital, says the study is important because many patients with the condition suffer permanent vision loss and there is no proven treatment for it.
"Recently, a small number of patients have responded to treatment with eplerenone and that is exciting, but information on the long-term benefit and safety is lacking, so we hope this landmark trial will establish the first scientifically proven therapy for CSCR,'' Lotery said.
Read the full story: